WordNet

a special situation; "this thing has got to end"; "it is a remarkable thing"
a separate and self-contained entity
an action; "how could you do such a thing?"
an artifact; "how does this thing work?"
an entity that is not named specifically; "I couldnt tell what the thing was"
any attribute or quality considered as having its own existence; "the thing I like about her is ..."
a persistent illogical feeling of desire or aversion; "he has a thing about seafood"; "she has a thing about him"
a special abstraction; "a thing of the spirit"; "things of the heart"
a special objective; "the thing is to stay in bounds"
a statement regarded as an object; "to say the same thing in other terms"; "how can you say such a thing?"
an event; "a funny thing happened on the way to the..."
type genus of the family Cancridae (同)genus Cancer
the fourth sign of the zodiac; the sun is in this sign from about June 21 to July 22 (同)Cancer the Crab, Crab
(astrology) a person who is born while the sun is in Cancer (同)Crab
a small zodiacal constellation in the northern hemisphere; between Leo and Gemini
any malignant growth or tumor caused by abnormal and uncontrolled cell division; it may spread to other parts of the body through the lymphatic system or the blood stream (同)malignant neoplastic disease

PrepTutorEJDIC

〈C〉(形のある)『物』,物体;(生物に対しての)『無生物』 / 〈C〉(形のない)『もの』,事,事柄,でき事 / 《複数形で》事情,事態,状勢,状況 / 《複数形で》(すべての)事物,事柄 / 《通例 the~》(努力・活動などの)目的,目標 / 〈C〉衣服,衣類・《one's things》持ち物,所持品,身の回り品 / 《複数形で》道具,用具・〈C〉《親愛・哀れみ・軽べつなどの感情をこめて》人,者,やつ / 《the~》《話》(…の)流行《+in+名》
《所有・所属》…『の』,…のものである,…に属する・《材料・要素》…『でできた』,から成る・《部分》…『の』[『中の』] ・《数量・単位・種類を表す名詞に付いて》…の・《原因・動機》…『で』,のために(because of) ・《主格関係》…『の』,による,によって・《目的格関係》…『を』,の・《同格関係》…『という』・《関係・関連》…『についての』[『の』],の点で・《抽象名詞などと共に》…の[性質をもつ] ・《『It is』+『形』+『of』+『名』+『to』 doの形で,ofの後の名詞を意味上の主語として》・《分離》…『から』・《起原・出所》…『から』[『の』](out of) ・《『名』+『of』+『a』(『an』)+『名』の形で》…のような・《『名』+『of』+『mine』(『yours, his』など独立所有格)の形で》…の…・《時》(1)《副詞句を作って》…に《形容詞句を作って》…の・《時刻》《米》…前(to,《米》before)
《前述の名詞または文脈でそれと分かる名詞に付けて》『その』,あの,名の / 《唯一の事物に付けて》 / 《方角・自然現象に付けて》 / 《用具・楽器・特定の病気などに付けて》 / 《修飾吾[句]を伴う名詞に付けて》 / 《単数普通名詞に付けて》(1)《種族全体》…『というもの』 / 《複数名詞または集合名詞に付けて》 / 《単位》『…につき;…単位[で]』 / 《身体の一部に付けて,所有格に代わる》 / 《形容詞に付けて》 / 《固有名詞に付けて》 / 《強意用法に》『随一の』,典型的な / 《「the+比較級,the+比較級」の形で》『…すればするほどそれだけ』 / 《比較級の前に》(…につれて,のために)『それだけ』,ますます
〈U〉〈C〉『がん』 / 〈U〉〈C〉害悪 / 《Cancer》(星座の)カニ座

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 子宮体癌：治療前評価、病期分類、および外科治療 endometrial carcinoma pretreatment evaluation staging and surgical treatment
2. 子宮体癌の概要 overview of endometrial carcinoma
3. 高リスクの子宮体癌に対する補助化学療法 adjuvant treatment of high risk endometrial cancers
4. 再発性または転移性子宮体癌の治療 treatment of recurrent or metastatic endometrial cancer
5. 子宮体癌：疫学および危険因子 endometrial carcinoma epidemiology and risk factors

English Journal

HER2 aberrations in cancer: Implications for therapy.

Yan M1, Parker BA2, Schwab R2, Kurzrock R2.
Cancer treatment reviews.Cancer Treat Rev.2014 Jul;40(6):770-780. doi: 10.1016/j.ctrv.2014.02.008. Epub 2014 Mar 12.
Although anti-HER2 (human epidermal growth factor receptor 2) therapy is currently approved for breast, gastric, and gastroesophageal cancers overexpressing the HER2 protein or amplified for the HER2 gene, HER2 aberrations (gene amplification, gene mutations, and protein overexpression) are reported
PMID 24656976

Use of SERMs for treatment in postmenopausal women.

Pinkerton JV1, Thomas S2.
The Journal of steroid biochemistry and molecular biology.J Steroid Biochem Mol Biol.2014 Jul;142C:142-154. doi: 10.1016/j.jsbmb.2013.12.011. Epub 2013 Dec 25.
Selective estrogen receptor modulators (SERMs) are synthetic non-steroidal agents which have varying estrogen agonist and antagonist activities in different tissues, most likely due to the receptor conformation changes associated with that SERM's binding and the subsequent effect on transcription. C
PMID 24373794

Endometrial Stromal Sarcomas: Immunoprofile With Emphasis on HMB45 Reactivity.

Albores-Saavedra J1, Dorantes-Heredia R2, Chablé-Montero F3, Chanona-Vilchis J4, Pérez-Montiel D4, Lino-Silva LS3, González-Romo MA5, Ramírez-Jaramillo JM3, Henson DE6.
American journal of clinical pathology.Am J Clin Pathol.2014 Jun;141(6):850-5. doi: 10.1309/AJCPS88CMJRXZBWA.
OBJECTIVES: We describe the morphologic and immunohistochemical features of 17 endometrial stromal neoplasms, 16 sarcomas, and one stromal nodule.METHODS: We reviewed 35 cases interpreted as endometrial stromal neoplasms, but 17 high-grade endometrial stromal sarcomas (ESS) and one case of mixed end
PMID 24838330

Japanese Journal

子宮体部混合癌の1例

土田秀,鹿沼達哉,神山晴美,布瀬川卓也,飯島美砂,中里宜正,小島勝,杉原志朗
日本臨床細胞学会雑誌 51(6), 431-434, 2012-11-22
NAID 10031125987

1) エストロゲン(E)受容体の機能解析と抗老化分子SIRT1のE標的組織への作用に基いた新規ホルモン補充療法の開発に向けた研究(シンポジウム1:女性ヘルスケア「中高年に対する女性医学の展開」,第64回日本産科婦人科学会・学術講演会)

平池修
日本産科婦人科學會雜誌 64(10), 2167-2179, 2012-10-01
… Estrogens are used for the reduction of postmenopausal symptoms and for the preservation of bone mineral density, but recent epidemiological studies suggest that combined estrogen and progestogen hormone replacement therapy (HRT) possesses several detrimental effects. …
NAID 110009518073

Tumor Angiogenesis and Anti-angiogenic Therapy

KUBOTA Yoshiaki
Keio journal of
… Anti-angiogenic therapy is an anti-cancer strategy that targets the new vessels that grow to provide oxygen and nutrients to actively proliferating tumor cells. … Most of the current anti-cancer reagents used in the clinical setting indiscriminately target all rapidly dividing cells, resulting in severe adverse effects such as immunosuppression, intestinal problems and hair loss. …
NAID 10030771295